Below is Valide’s guru traditional file for CRISPR THERAPEUTICS AG (CRSP). Of the 22 guru suggestions we take into account, CRSP charges the perfect use of our Stamp Investor dummy in response to Benjamin Graham’s published technique. This deep mark methodology shows up for stocks that have low P/B and P/E ratios, on the low debt side, and solid long-term earnings.
CRISPR THERAPEUTICS AG (CRSP) is a mid-cap stock in the biotechnology and pharmaceuticals revolution. The estimate using this design is 43% in response to the agency’s fundamentals and the stock’s valuation. Around 80% or more usually means that the technique has some ardor in the stock, and anything above 90% usually indicates accurate ardor.
The following table summarizes whether or not the stock meets any and all tests of this design. All criteria in the table below are no longer equally weighted or self-contained, but the table provides a quick overview of the precise and weak security capabilities in the context of the technique criteria.
| SECTOR: | PASS |
| SALE: | FAILED |
| CURRENT RELATIONSHIP: | PASS |
| LONG-TERM DEBT BASED ON NET WORKING ASSETS: | PASS |
| LONG-TERM EPS GROWTH: | FAILED |
| P/E RATIO: | FAILED |
| PRICE/BOOK RATIO: | FAILED |
Detailed analysis of CRISPR THERAPEUTICS AG
CRSP Guru Analysis
The most fundamental CRSP analysis
Additional details about Benjamin Graham
Benjamin Graham Portfolio
Benjamin Graham’s Best Stocks
About Benjamin Graham: The late Benjamin Graham might be the oldest of the gurus we follow, but his influence on the investment world continues decades after he lost his life in 1976. Most commonly known as the “Father of Postage Stamp Investing” and as the founder of the entire discipline of security forecasting, Graham mentored many of the greatest traders in historical past – in addition to Warren Buffett – and inspired a host of others, in addition to John Templeton, Mario Gabelli and another Validee Guru, John Neff. Graham acquired his wealth and reputation after surviving some extremely sophisticated cases, both during the good depression and the financial difficulties of his own household following the loss of his father’s life when Benjamin became a younger man. His investment agency posted returns of about 20 percent each year from 1936 to 1956, well above the 12.2 percent average return for the market during that time.
Additional Links Be Educated
The best healthcare stocks
Dividend Aristocrats 2025
Huge Moat shares
Recession-proof stocks
Stocks with high insider ownership
Stock portfolios that are fundamentally factor-based
About Validea: Validea is an investment research service that follows the published suggestions of investment legends. Validea offers stock forecasts and model portfolios in response to gurus who have outperformed the market over the long term, in addition to Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information on Validea, click here
The views and opinions expressed herein are those of the creator and construct and are no longer necessarily conveyed by Nasdaq, Inc.
Leave a Reply